Tickbird
Back to the test bench

The product's shortlist

Shortlist, numbers only

Sessions

24

first reading at 60

Mean return

-4.91%

Open to close, per session

vs S&P 500

-4.89%

t = -1.36

Verdict

no verdict yet

24 of the 60 sessions before the first reading. No verdict until then.

The hypothesis, as registered

The models add noise, not signal. The re-scored quantitative rank — which already counts the morning's pre-market trade, the fresh headlines and the next earnings date — does as well on its own.

The rule

The finalist with the highest re-scored quantitative score. No model verdict is read.

Registered on 2026-09-07. Neither text has changed since, and neither will: a strategy that needs amending is retired and a new one registered in its place.

Session by session

Newest first. The numbers in the middle column are the ones the rule actually read that morning. Losing days stay.

SessionPickWhat the rule readReturnvs S&P 500
2026-10-14VRAVera Bradley, Inc.quant score 59.3 · pre-market gap +0.52% · entry queue quantpendingpending
2026-10-13CCCCCC Intelligent Solutions Holdings Inc.quant score 72.9 · pre-market gap -0.53% · entry queue quant+2.49%+2.40%
2026-10-12NVAXNovavax, Inc.quant score 72.7 · pre-market gap -1.02% · entry queue quantno price found—
2026-10-09MANEVeradermics, Incorporatedquant score 78.8 · entry queue quant+4.13%+3.83%
2026-10-08XRPNArmada Acquisition Corp. IIquant score 74.0 · pre-market gap +6.00% · entry queue quantno price found—
2026-10-07APUSApimeds Pharmaceuticals US, Inc.quant score 79.0 · pre-market gap +11.92% · entry queue quant-11.88%-12.06%
2026-10-06DNAGinkgo Bioworks Holdings, Inc. Class Aquant score 78.4 · pre-market gap +2.03% · entry queue quant-17.71%-17.83%
2026-10-05SDEVStablecoin Development Corporationquant score 85.7 · pre-market gap +52.08% · entry queue quant-59.42%-60.09%
2026-10-02XRPNArmada Acquisition Corp. IIquant score 82.1 · pre-market gap +7.17% · entry queue quant+35.93%+36.05%
2026-10-01PGENPrecigen, Inc.quant score 82.2 · pre-market gap +1.05% · entry queue quant-3.41%-3.36%
2026-09-30IOVAIovance Biotherapeutics, Inc.quant score 88.3 · pre-market gap +1.66% · entry queue quant+0.89%+1.38%
2026-09-29AGENAgenus Inc.quant score 76.0 · pre-market gap +1.29% · entry queue quant+3.24%+3.58%
2026-09-28QMCOQuantum Corporationquant score 78.3 · pre-market gap -1.04% · entry queue quant-0.79%-0.43%
2026-09-25GLNDGreenland Energy Companyquant score 94.0 · pre-market gap +18.13% · entry queue quant-8.58%-8.92%
2026-09-24SECZSecuritize Corp.quant score 80.3 · pre-market gap -0.35% · entry queue quant+12.68%+12.27%
2026-09-23FIVNFive9, Inc.quant score 83.7 · pre-market gap +6.38% · entry queue quant-3.36%-2.72%
2026-09-22VEEETwin Vee PowerCats Co.quant score 86.0 · pre-market gap +2.61% · entry queue quant-13.55%-13.47%
2026-09-21PURRHyperliquid Strategies Incquant score 90.1 · pre-market gap +4.83% · entry queue quant-7.51%-8.45%
2026-09-18SECZSecuritize Corp.quant score 89.0 · pre-market gap +5.82% · entry queue quant+16.52%+16.47%
2026-09-17MEDSDataMeds AI, Inc.quant score 86.7 · pre-market gap +9.23% · entry queue quant-30.85%-30.78%
2026-09-16SDGRSchrodinger, Inc.quant score 84.5 · pre-market gap +2.54% · entry queue quant+2.75%+3.47%
2026-09-15DBIDesigner Brands Inc. Class Aquant score 84.4 · entry queue quant-3.85%-3.49%
2026-09-14ACVAACV Auctions Inc. Class Aquant score 82.5 · pre-market gap +0.19% · entry queue quant-0.10%-0.34%
2026-09-11PCLAPicoCELA Inc.quant score 86.0 · pre-market gap +23.77% · entry queue quant-19.63%-19.58%
2026-09-10IRDOpus Genetics, Inc.quant score 88.2 · pre-market gap +3.32% · entry queue quant+3.23%+3.26%
2026-09-09BNCCEA Industries Inc.quant score 87.9 · pre-market gap +3.24% · entry queue quant-13.73%-13.51%
2026-09-08CHPTChargePoint Holdings, Inc.quant score 85.3 · pre-market gap +2.11% · entry queue quant-5.45%-5.04%

Best session +35.93%, worst -59.42%. Over this few sessions the mean is mostly the sum of its two or three largest days, which is the whole reason the verdict is read only after 60, 120, 250, 500 sessions and frozen in between.

This is not investment advice. Tickbird is an automated experiment. It publishes a general analysis, not a personal recommendation, and it makes no promise about any outcome. Past results do not predict future ones. Never risk money you cannot afford to lose.